Press Releases

12/10/2019

New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium

Northwestern University researchers use gold standard  liquid-biopsy technology to deepen understanding of metastatic breast cancer

continue →

Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, metastatic breast cancer, rare cells

10/31/2019

Menarini Silicon Biosystems to Debut VRNxT Technology at 25th Annual Meeting of the Association for Molecular Pathology

Automated volume reduction instrument increases precision and accuracy in rare cell workflows

continue →

Topics: Liquid biopsy, Precision Medicine, rare cells, volume reduction, VRNxT

09/23/2019

Menarini Silicon Biosystems to Host ESMO Symposium on Clinical Importance of Circulating Tumor Cells

World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer

continue →

Topics: CTCs, Liquid biopsy, Precision Medicine, rare cells

05/30/2019

CellSearch Studies at ASCO Show Potential Predictive Role for Circulating Tumor Cells in Metastatic Breast Cancer

Liquid biopsy data reveals “intriguing” association between ESR1 mutations, HER2 alterations and prognosis

continue →

Topics: CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer

03/27/2019

New CellSearch Data To Be Presented at AACR Deepens Understanding of Metastatic Breast Cancer

Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker

continue →

Topics: deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer, lynphoma, CTC cluster, melanoma

03/12/2019

Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells

Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression

continue →

Topics: FFPE, deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, Multiple myeloma, CMMCs

11/29/2018

New Studies Using CELLSEARCH Circulating Tumor Cell Test to be Featured at San Antonio Breast Cancer Symposium

Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients

continue →

Topics: CTCs, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer

03/12/2018

A robust method to study cancer heterogeneity in liquid biopsy

Copy Number Alteration Profiling of Single Circulating Tumor Cells which May Be used to Predict Response to Therapy

continue →

Topics: CTCs, DEPArray NxT, NGS, CELLSEARCH, Liquid biopsy, Precision Medicine, low-pass, copy number alteration

05/16/2017

Top International Experts Gather to Understand the Many Faces of Cancer

Second World Summit on Cancer Heterogeneity and Precision Medicine Meets in Washington

continue →

Topics: FFPE, CTCs, Liquid biopsy, International experts, Menarini International Foundation, Precision Medicine, Cancer Heterogeneity, International conference

04/3/2017

Menarini-Silicon Biosystems Completes Acquisition of CELLSEARCH® Assets

Liquid Biopsy Test for Circulating Tumor Cells Marks Its First Entry into U.S. Diagnostics Market

continue →

Topics: CTCs, deparray, CELLSEARCH, acquisition, CTC test, Liquid biopsy